Filing Details
- Accession Number:
- 0001127602-11-017746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-27 16:11:47
- Reporting Period:
- 2011-05-26
- Filing Date:
- 2011-05-27
- Accepted Time:
- 2011-05-27 15:11:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236188 | W Robert Pangia | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-05-26 | 10,000 | $68.15 | 24,080 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-05-26 | 5,000 | $34.34 | 29,080 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-05-26 | 12,800 | $93.04 | 16,280 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-05-26 | 2,200 | $93.50 | 14,080 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-26 | 10,000 | $0.00 | 10,000 | $68.15 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-26 | 5,000 | $0.00 | 5,000 | $34.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2003-01-02 | 2012-01-01 | No | 4 | M | Direct |
5,000 | 2005-01-02 | 2014-01-01 | No | 4 | M | Direct |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $92.42 (low) and $93.41 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares sold at a range between $93.43 (low) and $93.59 (high).